Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp

<< Previous

Bullboard Posts

Next >>

Post by WakeUPPon Oct 04, 2021 9:46pm

136 Views

Post# 33965336

read this

THIS is a good article

https://thedeepdive.ca/the-skeptical-investors-guide-to-reading-a-corporate-press-release/

READ IT

then go back and read LEXX, and the paid promos (zaks "research "lol) etc

THEN you might understand. (skylight it too far off thw deepend to ever understand)

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale